Clinical and Molecular Studies in Families With Inherited Eye Disease
Background: Genes are the basic units of heredity. When genes are changed, certain cells don t work like they should.
Official registry: https://clinicaltrials.gov/study/NCT02771236 · National Eye Institute (NEI) · enrollment listed as 5,000
What this phase means
This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.
They plan to enroll about 5,000 people at 10 sites. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Clinical and Molecular Studies in Families With Inherited Eye Disease
Primary outcome (registry wording): Document the clinical and genetic features of Mendelian and age related visual disorders
Who it is for (from inclusion criteria)
- Ages 4 Years to 120 Years
- To be eligible, the following who can join must be met, where applicable;
- Participant must be four years of age or older
- Individuals or family members of individuals with inherited eye diseases, either congenital, childhood, or age related
- All participants must be able to cooperate with study examination and phlebotomy
Who the registry excludes
- A participant is not eligible if any of the following
Public study contact (from the registry)
James F Hejtmancik, M.D.
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
10 listed- University of California, San Diego — La Jolla, California (recruiting)
- National Institutes of Health Clinical Center — Bethesda, Maryland (recruiting)
- Duke University Eye Center — Durham, North Carolina (withdrawn)
+ 7 sites outside the US on the same record
FAQ about this NCT record
Is NCT02771236 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT02771236?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT02771236?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary